Trial Outcomes & Findings for Body Weight Supported Treadmill Training Following Hip Fracture (NCT NCT00197496)
NCT ID: NCT00197496
Last Updated: 2017-03-30
Results Overview
Compliance to BWSTT only,
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
21 participants
Primary outcome timeframe
3 months
Results posted on
2017-03-30
Participant Flow
Patients treated for a hip fracture by orthopedic surgeons and admitted to the inpatient rehabilitation floor of a teaching hospital between September 2006 and November 2007 were considered for participation. A break in recruitment was implemented from November to early January to avoid variation in physiotherapy care related to holidays.
Participant milestones
| Measure |
BWSTT
Body weight supported treadmill training
|
Control
Usual care
|
|---|---|---|
|
Baseline to Discharge
STARTED
|
14
|
7
|
|
Baseline to Discharge
COMPLETED
|
12
|
5
|
|
Baseline to Discharge
NOT COMPLETED
|
2
|
2
|
|
Follow-up
STARTED
|
12
|
5
|
|
Follow-up
COMPLETED
|
10
|
4
|
|
Follow-up
NOT COMPLETED
|
2
|
1
|
Reasons for withdrawal
| Measure |
BWSTT
Body weight supported treadmill training
|
Control
Usual care
|
|---|---|---|
|
Baseline to Discharge
not interested
|
1
|
0
|
|
Baseline to Discharge
MRSA
|
1
|
0
|
|
Baseline to Discharge
Physician Decision
|
0
|
1
|
|
Baseline to Discharge
Protocol Violation
|
0
|
1
|
|
Follow-up
Lost to Follow-up
|
2
|
1
|
Baseline Characteristics
Some participants could not complete performance based measures at baseline.
Baseline characteristics by cohort
| Measure |
BWSTT
n=14 Participants
Body weight supported treadmill training
|
Control
n=7 Participants
Usual care
|
Total
n=21 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=14 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=21 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=14 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=21 Participants
|
|
Age, Categorical
>=65 years
|
14 Participants
n=14 Participants
|
7 Participants
n=7 Participants
|
21 Participants
n=21 Participants
|
|
Age, Continuous
|
79.9 years
STANDARD_DEVIATION 7.0 • n=14 Participants
|
83.7 years
STANDARD_DEVIATION 8.6 • n=7 Participants
|
81.2 years
STANDARD_DEVIATION 7 • n=21 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=14 Participants
|
6 Participants
n=7 Participants
|
18 Participants
n=21 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=14 Participants
|
1 Participants
n=7 Participants
|
3 Participants
n=21 Participants
|
|
Timed up and go time
|
73.9 seconds
STANDARD_DEVIATION 29.1 • n=8 Participants • Some participants could not complete performance based measures at baseline.
|
45.6 seconds
STANDARD_DEVIATION 10.3 • n=4 Participants • Some participants could not complete performance based measures at baseline.
|
64.8 seconds
STANDARD_DEVIATION 27.8 • n=12 Participants • Some participants could not complete performance based measures at baseline.
|
|
2 Minute Walk Test time
|
18.7 metres
STANDARD_DEVIATION 18.9 • n=11 Participants • Some participants could not perform performance based measures at baseline
|
23.6 metres
STANDARD_DEVIATION 15.3 • n=7 Participants • Some participants could not perform performance based measures at baseline
|
20.6 metres
STANDARD_DEVIATION 17.3 • n=18 Participants • Some participants could not perform performance based measures at baseline
|
|
Lower Extremity Functional Score
|
16.6 units on a scale
STANDARD_DEVIATION 8 • n=14 Participants
|
25.7 units on a scale
STANDARD_DEVIATION 16.5 • n=7 Participants
|
19.7 units on a scale
STANDARD_DEVIATION 11.9 • n=21 Participants
|
|
Falls Self-efficacy Scale
|
22.4 units on a scale
STANDARD_DEVIATION 9.2 • n=14 Participants
|
22.0 units on a scale
STANDARD_DEVIATION 8.2 • n=7 Participants
|
22.2 units on a scale
STANDARD_DEVIATION 8.7 • n=21 Participants
|
PRIMARY outcome
Timeframe: 3 monthsCompliance to BWSTT only,
Outcome measures
| Measure |
BWSTT
n=14 Participants
Body weight supported treadmill training
|
Control
Usual care
|
|---|---|---|
|
Feasibility - # With > or = 60% Compliance, # Agreeing to Participate, # Returning for 3 Month Follow-up
# agreed to participate
|
14 Participants
|
—
|
|
Feasibility - # With > or = 60% Compliance, # Agreeing to Participate, # Returning for 3 Month Follow-up
#returned for 3 month followup
|
10 Participants
|
—
|
|
Feasibility - # With > or = 60% Compliance, # Agreeing to Participate, # Returning for 3 Month Follow-up
# with at least 60% compliance
|
6 Participants
|
—
|
SECONDARY outcome
Timeframe: dischargeOutcome measures
| Measure |
BWSTT
n=12 Participants
Body weight supported treadmill training
|
Control
n=5 Participants
Usual care
|
|---|---|---|
|
Timed up and Go
|
25.2 seconds
Standard Deviation 7.0
|
20.7 seconds
Standard Deviation 5.0
|
SECONDARY outcome
Timeframe: dischargeOutcome measures
| Measure |
BWSTT
n=12 Participants
Body weight supported treadmill training
|
Control
n=5 Participants
Usual care
|
|---|---|---|
|
Falls Self Efficacy
|
17.7 units on a scale
Standard Deviation 6.6
|
12.8 units on a scale
Standard Deviation 4.4
|
SECONDARY outcome
Timeframe: dischargeOutcome measures
| Measure |
BWSTT
n=8 Participants
Body weight supported treadmill training
|
Control
n=5 Participants
Usual care
|
|---|---|---|
|
2 Minute Walk Test
|
70.6 metres
Standard Deviation 17.3
|
79.4 metres
Standard Deviation 17.9
|
SECONDARY outcome
Timeframe: dischargeOutcome measures
| Measure |
BWSTT
n=12 Participants
Body weight supported treadmill training
|
Control
n=5 Participants
Usual care
|
|---|---|---|
|
Lower Extremity Functional Scale
|
35.3 units on a scale
Standard Deviation 7.5
|
46.4 units on a scale
Standard Deviation 7.2
|
Adverse Events
BWSTT
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Usual Care
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place